Literature DB >> 18369632

Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma.

Frank T C Tschirch1, Anja Struwe, Henrik Petrowsky, Irini Kakales, Borut Marincek, Dominik Weishaupt.   

Abstract

The purpose of this study was to assess the quality of biliary duct visualization using Gd-EOB-DTPA-enhanced magnetic resonance cholangiography (EOB-MRC) in patients with liver cirrhosis. Forty adult patients with liver cirrhosis (cirrhosis group) and 20 adult individuals with normal liver parenchyma (control group) underwent EOB-MRC using T1-weighted GRE imaging up to 180 min after Gd-EOB-DTPA administration. Two observers assessed the visualization of each biliary structure and the overall anatomical visualization of the biliary tree. Child-Pugh, MELD score and laboratory findings were compared. The grade of visualization for each evaluated biliary structure was statistically different in the two groups (P = 0.004 to <0.001). The overall EOB-MRC quality was rated as sufficient for anatomical visualization of the biliary tree in all individuals of the control group 20 min after Gd-EOB-DTPA application, but in only 16/40 patients (40%) of the cirrhosis group within 30 min after application. Analysis of the ROC curves revealed that the cut-off values, for non-sufficient visualization of the biliary tree 20 min after Gd-EOB-DTPA application, were MELD scores > or =11 and total serum bilirubin levels > or =30 micromol/l. Consecutively, EOB-MRC in patients with liver cirrhosis resulted in a decreased or even non-visualization of the biliary tree in a substantial percentage of patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18369632     DOI: 10.1007/s00330-008-0929-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  14 in total

1.  Volumetric mangafodipir trisodium-enhanced cholangiography to define intrahepatic biliary anatomy.

Authors:  V S Lee; N M Rofsky; G R Morgan; L W Teperman; G A Krinsky; P Berman; J C Weinreb
Journal:  AJR Am J Roentgenol       Date:  2001-04       Impact factor: 3.959

2.  Bile duct leaks after laparoscopic cholecystectomy: value of contrast-enhanced MRCP.

Authors:  M Aduna; J A Larena; D Martín; B Martínez-Guereñu; I Aguirre; E Astigarraga
Journal:  Abdom Imaging       Date:  2005 Jul-Aug

3.  Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation.

Authors:  M Bollow; M Taupitz; B Hamm; T Staks; K J Wolf; H J Weinmann
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

Review 4.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

5.  Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

Authors:  B Hamm; T Staks; A Mühler; M Bollow; M Taupitz; T Frenzel; K J Wolf; H J Weinmann; L Lange
Journal:  Radiology       Date:  1995-06       Impact factor: 11.105

6.  Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.

Authors:  Hun-Kyu Ryeom; Seong-Hun Kim; Jong-Yeol Kim; Hye-Jeong Kim; Jong-Min Lee; Yong-Min Chang; Yong-Sun Kim; Duk-Sik Kang
Journal:  Korean J Radiol       Date:  2004 Oct-Dec       Impact factor: 3.500

7.  Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients.

Authors:  Kenneth M Vitellas; Adam El-Dieb; Kuldeep K Vaswani; William F Bennett; John Fromkes; Christopher Ellison; James G Bova
Journal:  AJR Am J Roentgenol       Date:  2002-08       Impact factor: 3.959

8.  Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient?

Authors:  Ruth C Carlos; Jill D Branam; Qian Dong; Hero K Hussain; Isaac R Francis
Journal:  Acad Radiol       Date:  2002-11       Impact factor: 3.173

9.  Mangafodipir-enhanced magnetic resonance cholangiography for the diagnosis of bile duct leaks.

Authors:  Frank Pilleul; Yann Billaud; Guillaume Gautier; Olivier Monneuse; Arielle Crombé-Ternamian; Pascal Fouque; Pierre-Jean Valette
Journal:  Gastrointest Endosc       Date:  2004-06       Impact factor: 9.427

10.  Model for end-stage liver disease (MELD) and allocation of donor livers.

Authors:  Russell Wiesner; Erick Edwards; Richard Freeman; Ann Harper; Ray Kim; Patrick Kamath; Walter Kremers; John Lake; Todd Howard; Robert M Merion; Robert A Wolfe; Ruud Krom
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

View more
  42 in total

1.  Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement?

Authors:  Shinichi Nakamura; Kazuo Awai; Daisuke Utsunomiya; Tomohiro Namimoto; Takeshi Nakaura; Kosuke Morita; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2011-12-14       Impact factor: 2.374

Review 2.  CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree.

Authors:  T Hyodo; S Kumano; F Kushihata; M Okada; M Hirata; T Tsuda; Y Takada; T Mochizuki; T Murakami
Journal:  Br J Radiol       Date:  2012-03-14       Impact factor: 3.039

3.  Added value of gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography for the diagnosis of post-transplant biliary complications.

Authors:  Sonja Kinner; Tilman B Schubert; Adnan Said; Joshua D Mezrich; Scott B Reeder
Journal:  Eur Radiol       Date:  2017-04-13       Impact factor: 5.315

4.  Optimized high-resolution contrast-enhanced hepatobiliary imaging at 3 tesla: a cross-over comparison of gadobenate dimeglumine and gadoxetic acid.

Authors:  Alex Frydrychowicz; Scott K Nagle; Sharon L D'Souza; Karl K Vigen; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2011-07-12       Impact factor: 4.813

Review 5.  [New developments in MRI of the liver].

Authors:  N Bastati-Huber; H Prosch; S Baroud; S Magnaldi; W Schima; A Ba-Ssalamah
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

Review 6.  MRI evaluation of bile duct injuries and other post-cholecystectomy complications.

Authors:  Shilpa Reddy; Camila Lopes Vendrami; Pardeep Mittal; Amir A Borhani; Courtney C Moreno; Frank H Miller
Journal:  Abdom Radiol (NY)       Date:  2021-02-12

7.  Diagnostic value of Gd-EOB-DTPA-enhanced MR cholangiography in non-invasive detection of postoperative bile leakage.

Authors:  Melahat Kul; Ayşe Erden; Ebru Düşünceli Atman
Journal:  Br J Radiol       Date:  2017-02-09       Impact factor: 3.039

8.  Assessment of a postoperative anastomotic stricture following correction surgery of a type IVa choledochal cyst using Gd-EOB-DTPA-enhanced magnetic resonance cholangiography.

Authors:  Evangelos Perdikakis; Evangelia G Chryssou; Mairi Koulentaki; Elias Kouroumalis; Apostolos Karantanas
Journal:  Clin J Gastroenterol       Date:  2011-11-01

9.  Diffusion kurtosis imaging in the assessment of liver function: Its potential as an effective predictor of liver function.

Authors:  Daisuke Yoshimaru; Yasuo Takatsu; Yuichi Suzuki; Toshiaki Miyati; Yuhki Hamada; Ayumu Funaki; Ayumi Tabata; Chifumi Maruyama; Masahiko Shimada; Maki Tobari; Takayoshi Nishino
Journal:  Br J Radiol       Date:  2018-11-01       Impact factor: 3.039

10.  Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent.

Authors:  Peter Reimer; Rolf Vosshenrich
Journal:  Biologics       Date:  2010-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.